Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Duane C. Hassane(AstraZeneca (Singapore)), Maria Antonina Alas(Cornell University), Yang Hu(Cornell University), Bas J. Wouters(Erasmus MC), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Pinkal Desai(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Sang Min Lee(Seoul National University Hospital), Fatima Bhopalwala Ali(Cornell University), Gail J. Roboz(Cornell University)
Cited by 79
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k